Vasoconstriction and coronary artery spasm after drug-eluting stent placement

Journal of Invasive Cardiology

Volumn 18, Issue 12, 2006, Pages 593-

  Togni, Mario ^a   Eberli, Franz R ^b  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

RAPAMYCIN; SEROTONIN; VASODILATOR AGENT;

AORTA BALLOON; BETA RADIATION; CARDIOGENIC SHOCK; CORONARY ARTERY SPASM; CORONARY STENT; DRUG ELUTING STENT; ENDOTHELIAL DYSFUNCTION; HUMAN; HYPERSENSITIVITY REACTION; IN-STENT RESTENOSIS; NOTE; PERCUTANEOUS CORONARY INTERVENTION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; RADIATION DOSE; VASOCONSTRICTION; VASOMOTOR DISORDER;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ARTERIOSCLEROSIS; CORONARY RESTENOSIS; CORONARY VASOSPASM; DRUG DELIVERY SYSTEMS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; STENTS; VASOCONSTRICTION;

EID: 33846175053     PISSN: 10423931     EISSN: 15572501     Source Type: Journal    
DOI: None     Document Type: Note

References (13)

1. Brott BC, Anayiotos A, Chapman G, et al. Severe, diffuse coronary artery spasm after drug-eluting stent placement. J Invasive Cardiol 2006;18:584-592.
2. Wheatcroft S, Byrne J, Thomas M, MacCarthy P. Life-threatening coronary artery spasm following sirolimus-eluting stent deployment. J Am Coll Cardiol 2006;47:1911-1912.
3. Kim JW, Park CG, Seo HS, Oh DJ. Delayed severe multivessel spasm and aborted sudden death after Taxus stent implantation. Heart 2005;91:e15.
4. Scheinert D, Strnad V, Müller R, et al. High-dose intravascular ß-radiation after de novo stent implantation induces coronary artery spasm. Circulation 2002;105:1420-1423.
5. Fischell TA, Derby G, Tse TM, Stadius ML. Coronary artery vasoconstriction routinely occurs after percutaneous transluminal coronary angioplasty. A quantitative arteriographic analysis. Circulation 1988;78:1323-1334.
6. Fischell TA, Bausback KN, McDonald TV. Evidence for altered epicardial coronary artery autoregulation as a cause of distal coronary vasoconstriction after successful percutaneous transluminal coronary angioplasty. J Clin Invest 1990;86:575-584.
7. Togni M, Windecker S, Cocchia R, et al. Sirolimus-eluting stents associated with paradoxic coronary vasoconstriction. J Am Coll Cardiol 2005;46:231-236.
8. Hofma SH, van der Giessen WJ, van Dalen BM, et al. Indication of long-term endothelial dysfunction after sirolimus-eluting stent implantation. Eur Heart J 2006;27:166-170.
9. Togni M, Raeber L, Cocchia R, et al. Local vascular dysfunction after coronary paclitaxel-eluting stent implantation. Int J Cardiol 2006 (in press).
10. Kounis NG, Zavras GM. Histamine-induced coronary artery spasm: The concept of allergic angina. Br J Clin Pract 1991;45:121-128.
11. Nebeker J, Virmani R, Bennett C, et al. Hypersensitivity cases associated with drug-eluting stents. A review of available cases from the research on adverse drug events and reports (RADAR) project. J Am Coll Cardiol 2006;47:175-181.
12. Kotani J, Awata M, Nanto S, et al. Incomplete neointimal coverage of sirolimus-eluting stents. Angioscopic findings. J Am Coll Cardiol 2006;47:2108-2111.
13. McFadden EP, Stabile E, Regar E, et al. Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. Lancet 2004;364:1519-1521.